Vaccinex, Inc.
VCNX
Revenue
232.00k
▲128.00k▲123.08%
3 Months ChangeAssets
2.37M
▼-5.00M▼-67.87%
3 Months ChangeLiabilities
5.23M
▲519.00k▲11.01%
3 Months ChangeFree Cash Flow
-4.63M
▲457.00k▲8.98%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0001193125-24-235251
2024-09-19
Form 8-K
ID: 0001193125-24-221790
2024-09-13
Form 8-K
ID: 0001193125-24-218870
2024-08-20
Form 8-K
ID: 0001193125-24-203149
2024-08-14
Form 10-Q
ID: 0000950170-24-097217
2024-08-14
Form 8-K
ID: 0001193125-24-200272
2024-07-31
Form 8-K
ID: 0001193125-24-189569
2024-06-06
Form 8-K
ID: 0001193125-24-155612
2024-05-15
Form 10-Q
ID: 0000950170-24-060603
2024-05-09
Form 8-K
ID: 0001193125-24-135285